Allergic responses and aryl hydrocarbon receptor novel pathway of mast cell activation

Molecular Immunology

Volumn 63, Issue 1, 2015, Pages 69-73

  Sibilano, Riccardo ^a   Pucillo, Carlo E ^b   Gri, Giorgia ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Allergy; Aryl hydrocarbon receptor; FICZ; IL 17; Mast cells

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BETA DEFENSIN 2; CIGARETTE SMOKE; CXCL1 CHEMOKINE; DIOXIN; ESTROGEN RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 6; INTERLEUKIN 8; KYNURENIC ACID; KYNURENINE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MUCIN 5AC; MUCIN 5B; REACTIVE OXYGEN METABOLITE; RETINOIC ACID RECEPTOR; AHR PROTEIN, HUMAN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; IL6 PROTEIN, HUMAN;

AIR POLLUTANT; ALLERGIC ASTHMA; ALLERGIC REACTION; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMBUSTION; CYTOKINE PRODUCTION; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; EXHAUST GAS; FIBROBLAST; GAMMA DELTA T LYMPHOCYTE; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; MAST CELL; NONHUMAN; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TH17 CELL; BIOSYNTHESIS; HYPERSENSITIVITY; IMMUNOLOGY;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE; IMMUNOGLOBULIN E; INTERLEUKIN-13; INTERLEUKIN-17; INTERLEUKIN-6; MAST CELLS; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION;

EID: 84908551224     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.02.015     Document Type: Review

References (59)

1. Abel J., Haarmann-Stemmann T. An introduction to the molecular basics of aryl hydrocarbon receptor biology. Biol. Chem. 2010, 391:1235-1248.
2. Allen J.D., Jaffer Z.M., Park S.-J., Burgin S., Hofmann C., Sells M.A., Chen S., Derr-Yellin E., Michels E.G., McDaniel A., Bessler W.K., Ingram D.A., Atkinson S.J., Travers J.B., Chernoff J., Clapp D.W. p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics. Blood 2009, 113:2695-2705.
3. Andreola F., Fernandez-Salguero P.M., Chiantore M.V., Petkovich M.P., Gonzalez F.J., De Luca L.M. Aryl hydrocarbon receptor knockout mice (AHR-/-) exhibit liver retinoid accumulation and reduced retinoic acid metabolism. Cancer Res. 1997, 57:2835-2838.
4. Barczyk A., Pierzchala W., Sozañska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir. Med. 2003, 97:726-733.
5. Barnes P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 2008, 8:183-192.
6. Brusselle G.G., Joos G.F., Bracke K.R. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011, 378:1015-1026.
7. Busse W.W., Lemanske R.F. Asthma. N. Engl. J. Med. 2001, 344:350-362.
8. Cua D.J., Tato C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 2010, 10:479-489.
9. de Boer O.J., van der Meer J.J., Teeling P., van der Loos C.M., Idu M.M., van Maldegem F., Aten J., van der Wal A.C. Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques. J. Pathol. 2010, 220:499-508.
10. Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Ann. Rev. Pharm. Toxicol. 2003, 43:309-334.
11. Denison M.S., Pandini A., Nagy S.R., Baldwin E.P., Bonati L. Ligand binding and activation of the Ah receptor. Chem. Biol. Interact. 2002, 141:3-24.
12. DiNatale B.C., Schroeder J.C., Francey L.J., Kusnadi A., Perdew G.H. Mechanistic insights into the events that lead to synergistic induction of interleukin 6 transcription upon activation of the aryl hydrocarbon receptor and inflammatory signaling. J. Biol. Chem. 2010, 285:24388-24397.
13. Duarte J.H., Di Meglio P., Hirota K., Ahlfors H., Stockinger B. Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses in vitro and in vivo. PLoS ONE 2013, 8:e79819.
14. Esser C., Rannug A., Stockinger B. The aryl hydrocarbon receptor in immunity. Trends Immunol. 2009, 30:447-454.
15. Galli S.J., Grimbaldeston M., Tsai M. Immunomodulatory mast cells: negative, as well as positive regulators of immunity. Nat. Rev. Immunol. 2008, 8:478-486.
16. Gri G., Piconese S., Frossi B., Manfroi V., Merluzzi S., Tripodo C., Viola A., Odom S., Rivera J., Colombo M.P., Pucillo C.E. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 2008, 29:771-781.
17. Gri G., Frossi B., D'Inca F., Danelli L., Betto E., Mion F., Sibilano R., Pucillo C. Mast cell: an emerging partner in immune interaction. Front. Immunol. 2012, 3:120.
18. Hahn M.E., Allan L.L., Sherr D.H. Regulation of constitutive and inducible AHR signaling: complex interactions involving the AHR repressor. Biochem. Pharmacol. 2009, 77:485-497.
19. Hämäläinen M., Nieminen R., Vuorela P., Heinonen M., Moilanen E. Anti-inflammatory effects of flavonoids: genistein kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. 2007, 2007:45673.
20. Hauben E., Gregori S., Draghici E., Migliavacca B., Olivieri S., Woisetschläger M., Roncarolo M.G. Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells. Blood 2008, 112:1214-1222.
21. Hueber A.J., Asquith D.L., Miller A.M., Reilly J., Kerr S., Leipe J., Melendez A.J., McInnes I.B. Mast cells express IL-17A in rheumatoid arthritis synovium. J. Immunol. 2010, 184:3336-3340.
22. Joseph K., Kaplan A.P. Formation of bradykinin: a major contributor to the innate inflammatory response. Adv. Immunol. 2005, 86:159-208.
23. Kaneko Y., Yatagai Y., Yamada H., Iijima H., Masuko H., Sakamoto T., Hizawa N. The search for common pathways underlying asthma and COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 2013, 8:65-78.
24. Kerkvliet N.I. Ahr-mediated immunomodulation: the role of altered gene transcription. Biochem. Pharm. 2009, 77:746-760.
25. Kerkvliet N.I., Steppan L.B., Vorachek W., Oda S., Farrer D., Wong C.P., Pham D., Mourich D.V. Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes. Immunotherapy 2009, 1:539-547.
26. Kinyanjui M.W., Shan J., Nakada E.M., Qureshi S.T., Fixman E.D. Dose-dependent effects of IL-17 on IL-13-induced airway inflammatory responses and airway hyperresponsiveness. J. Immunol. 2013, 190:3859-3868.
27. Klinge C.M., Kaur K., Swanson H.I. The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRalpha1. Arch. Biochem. Biophys. 2000, 373:163-174.
28. Lin A.M., Rubin C.J., Khandpur R., Wang J.Y., Riblett M., Yalavarthi S., Villanueva E.C., Shah P., Kaplan M.J., Bruce A.T. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J. Immunol. 2011, 187:490-500.
29. Ma Q. Induction of CYP1A1. The AhR/DRE paradigm: transcription, receptor regulation, and expanding biological roles. Curr. Drug Metab. 2001, 2:149-164.
30. Maaetoft-Udsen K., Shimoda L.M.N., Frøkiær H., Turner H. Aryl hydrocarbon receptor ligand effects in RBL2H3 cells. J. Immunotoxicol. 2012, 9:327-337.
31. Martin B., Hirota K., Cua D.J., Stockinger B., Veldhoen M. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009, 31:321-330.
32. Molet S., Hamid Q., Davoine F., Nutku E., Taha R., Pagé N., Olivenstein R., Elias J., Chakir J. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 2001, 108:430-438.
33. Monteleone I., Rizzo A., Sarra M., Sica G., Sileri P., Biancone L., Macdonald T.T., Pallone F., Monteleone G. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology 2011, 141:237-248. e231.
34. Nebert D.W., Roe A.L., Dieter M.Z., Solis W.A., Yang Y., Dalton T.P. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response cell cycle control and apoptosis. Biochem. Pharmacol. 2000, 59:65-85.
35. Noordenbos T., Yeremenko N., Gofita I., van de Sande M., Tak P.P., Caňete J.D., Baeten D. Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis. Arthritis Rheum. 2012, 64:99-109.
36. Oboki K., Ohno T., Saito H., Nakae S. Th17 and allergy. Allergol. Int. 2008, 57:121-134.
37. Peden D.B., Bush R.K. Advances in environmental and occupational disorders in 2012. J. Allergy Clin. Immunol. 2013, 131:668-674.
38. Qiu J., Heller J.J., Guo X., Chen Z.-M.E., Fish K., Fu Y.-X., Zhou L. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 2012, 36:92-104.
39. Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E., Caccamo M., Oukka M., Weiner H.L. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008, 453:65-71.
40. Rier S.E., Martin D.C., Bowman R.E., Dmowski W.P., Becker J.L. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam. Appl. Toxicol. 1993, 21:433-441.
41. Schulz V.J., Smit J.J., Willemsen K.J., Fiechter D., Hassing I., Bleumink R., Boon L., van den Berg M., van Duursen M.B.M., Pieters R.H.H. Activation of the aryl hydrocarbon receptor suppresses sensitization in a mouse peanut allergy model. Toxicol. Sci. 2011, 123:491-500.
42. Shen E.S., Whitlock J.P. Protein-DNA interactions at a dioxin-responsive enhancer. Mutational analysis of the DNA-binding site for the liganded Ah receptor. J. Biol. Chem. 1992, 267:6815-6819.
43. Sibilano R., Frossi B., Calvaruso M., Danelli L., Betto E., Dall'agnese A., Tripodo C., Colombo M.P., Pucillo C.E., Gri G. The aryl hydrocarbon receptor modulates acute and late mast cell responses. J. Immunol. 2012, 189:120-127.
44. Sibilano R., Frossi B., Suzuki R., D'Incà F., Gri G., Piconese S., Colombo M.P., Rivera J., Pucillo C.E. Modulation of Fce{open}RI-dependent mast cell response by OX40L via Fyn, PI3K, and RhoA. J. Allergy Clin. Immunol. 2012, 130:751-760.
45. Singh N.P., Singh U.P., Singh B., Price R.L., Nagarkatti M., Nagarkatti P.S. Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis. PLoS ONE 2011, 6:e23522.
46. Smith M.J., Garrett R.H. A heretofore undisclosed crux of eosinophilia-myalgia syndrome: compromised histamine degradation. Inflamm. Res. 2005, 54:435-450.
47. Sogawa K., Fujii-Kuriyama Y. Ah receptor, a novel ligand-activated transcription factor. J. Biochem. 1997, 122:1075-1079.
48. Stange J., Veldhoen M. The aryl hydrocarbon receptor in innate T cell immunity. Semin. Immunopathol. 2013, 35:645-655.
49. Stejskalova L., Dvorak Z., Pavek P. Endogenous and exogenous ligands of aryl hydrocarbon receptor: current state of art. Curr. Drug Metab. 2011, 12:198-212.
50. Stockinger B., Hirota K., Duarte J., Veldhoen M. External influences on the immune system via activation of the aryl hydrocarbon receptor. Semin. Immunol. 2011, 23:99-105.
51. Sugamata M., Ihara T., Uchiide I. Increase of activated mast cells in human endometriosis. Am. J. Reprod. Immunol. 2005, 53:120-125.
52. Sun Y.V., Boverhof D.R., Burgoon L.D., Fielden M.R., Zacharewski T.R. Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences. Nucleic Acids Res. 2004, 32:4512-4523.
53. Suurmond J., Dorjée A.L., Boon M.R., Knol E.F., Huizinga T.W., Toes R.E., Schuerwegh A.J. Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium. Arthritis Res. Ther. 2011, 13:R150.
54. Swindle E.J., Metcalfe D.D. The role of reactive oxygen species and nitric oxide in mast cell-dependent inflammatory processes. Immunol. Rev. 2007, 217:186-205.
55. Urboniene D., Babusyte A., Lötvall J., Sakalauskas R., Sitkauskiene B. Distribution of γδ and other T-lymphocyte subsets in patients with chronic obstructive pulmonary disease and asthma. Respir. Med. 2013, 107:413-423.
56. Veldhoen M., Hirota K., Westendorf A.M., Buer J., Dumoutier L., Renauld J.-C., Stockinger B. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008, 453:106-109.
57. Vernon M.K., Wiklund I., Bell J.A., Dale P., Chapman K.R. What do we know about asthma triggers? A review of the literature. J. Asthma 2012, 49:991-998.
58. Weiner H.L., da Cunha A.P., Quintana F., Wu H. Oral tolerance. Immunol. Rev. 2011, 241:241-259.
59. Zhou Y., Tung H.-Y., Tsai Y.-M., Hsu S.-C., Chang H.-W., Kawasaki H., Tseng H.-C., Plunkett B., Gao P., Hung C.-H., Vonakis B.M., Huang S.-K. Aryl hydrocarbon receptor controls murine mast cell homeostasis. Blood 2013, 121:3195-3204.